Member Info for Kingping25

If you want to email me on kingping25@hotmail.co.uk with your name no I will call you for a chat

Source on both points - discussions with senior management.

Letter conformation - any day

Recruitment update

Investor presentation with valuation discussions

Cbr updates

Consolidation

First injection

Big investor to progress company to phase 1 start of phase two after consolidation

Results on grant approval Q1 2025 for cbr

Car t therepy works people and if this version is successful your gonna kick yourselves to not get entry at this level. Remember phase 1 is all about safety and not results. Phase 1 to 2 is a quick process.

19.4 million yes from me

Anyone shorting this right now is insane. We are clinical and this is worth 100,s of millions if successful on phase 1 which is highly likely.

My understanding is this is agreed and printed and as of Tues they were awaiting formal receipt of it. It was an any day arriving conversation. We had thanksgiving in us yesterday so they shut down for the day. The essay that they did and issued an rns about a while back identifies patients globo co (you know co) has ready, they would have actioned this and know who is the best candidate. You’re gonna get a bazoka of news shortly.

Everything is true and loads of positive news to come. Recruitment process has I believe started and the patient which is probably already found goes through there tests (if not already started) to confirm eligibility. There blood is then sent to Hemogenyx for T cells to be extracted and manufactured ready for first injection. This is as good as it gets and the process has started. I’m so excited about this company and what 2025 will bring.

Re funds these larger companies do not have discounts generally but future warrants on success and agree a plan to help to develop a business not retail investors playing games.

I,d sell out if I were you and keep what you can. Good bye you’re gonna burn. 🔥

A phase 1 company in car t trials is worth 35 mil minimum. That’s 2.6p or £10 in new money and this will get back there. The valuation by so angel and pravail is double this figure. This 35 mil cap is without all there other products, ability to manufacturer cells for other companies. The train is leaving people choo choo

Things take time and planning, watch this space!! When this moves it’s gonna move fast.

New money is 1p = £4. 3p = £12 etc etc

Deffered shares are not even to be looked at they are not listed, not traded, have no voting rights and worth nothing in reality.

Yes - if phase 1 is a success this could be valued heavily north of 150m and that’s 10p or £40 in new money.

People need to wake up and not miss this amazing opportunity .

Expect a huge investment presentation soon, expect first injection, expect potential director confidence of share buying, expect big funds to follow. Jump on board now or pay a higher premium later.

Let’s say conservatively a phase 1 co with success in car t trials is worth 150m and that’s being really conservative and insulting to the potential here. That’s 10 times market cap to now and with a high success rate in phase 1 trials (80%) that’s 10 times todays market cap which you could have data within 4/5 months to prove this. This is a bargain beyond bargain and potential licience to print money if you willing to take the risk. Be brave when others are fearful and fearful when others are brave. (Warren Buffett)

Sorry £42k in todays money at 1.2p

The sub division is the last headroom of 3.5m shares and only worth 60k max. He was trying to soften the confusion and blow to lth,s. I would ignore it tbh. Your only get this if co ever sells or gets bought out in shares from a large pharma

Now I meant

Makes no sense Goldwater. An interview is coming, first injection is coming, md Anderson sign off is coming and cbr updates coming. That’s fact. Your obv a shorter or you do not understand the situation. The fact is hemo are not in best position since I’ve been invested for 4 years

This is a chance to buy in cheap shares, there is no dilution and I’m gonna try and explain the situation in simple terms as the rns did not.

Any shares you have right now will be divided by 400. So £0.012p is what 1 share is worth now and for every 400 you have you will have 1 given to you in todays money at £4.80. The market cap will stay the same and there is no dilution.

The deferred shares is clearly the left over headroom they currently have which is 3.5million shares. Which is 1.4billion shares divided by 400. They are giving you some free shares here but it’s not worth allot for example if you held 5million shares you will get another 5 million shares but this is then divided by 400 in real terms so you would recieve a free 12500 shares at a value in todays terms of £150 that can be cashed in when the company reaches certain threshold points.

The company needs access to big funds in the future, not 2,3 or even 5 million but tens of millions and if the data is good from trials they will need a huge partner to buy in. So doing this 400-1 allows them to do so as big pharma will not deal will penny share companies. The company also plans I believe to change from lse to Nasdaq when the market cap allows it and the minimum share to do this is $4 dollars a share. This will be us exposed to a much larger market group and companies are generally valued at allot more.

He also wants to wipe out the shorters of this world by doing this as big investment will not churn there shares and stop the nonsense. The delivery was poor but the plan is good. I’m in finance and it took me ages to understand it.

As of two weeks ago md Anderson were ready and the essay detailed 1 month ago identifying these patients was launched. This is about to get hot with first patient news inbound shortly. Train is about to leave station.

Phase 2 was a flop

With human data yes but without I don,t think so. Look at synairgen before their results came out as successful phase 1 for covid. Went from 35m to 500m on success and then collapsed when phase one was a flop